ID   MEF2D_RAT               Reviewed;         507 AA.
AC   O89038; Q66HL8;
DT   24-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   24-JUL-2024, entry version 141.
DE   RecName: Full=Myocyte-specific enhancer factor 2D;
GN   Name=Mef2d;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH MAPK7.
RC   STRAIN=Wistar; TISSUE=Heart;
RX   PubMed=9753748; DOI=10.1093/nar/26.20.4771;
RA   Yang C.-C., Ornatsky O.I., McDermott J.C., Cruz T.F., Prody C.A.;
RT   "Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated
RT   protein kinase, ERK5/BMK1.";
RL   Nucleic Acids Res. 26:4771-4777(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-106; SER-121;
RP   SER-180; SER-231 AND SER-251, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional activator which binds specifically to the
CC       MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific,
CC       growth factor- and stress-induced genes. Mediates cellular functions
CC       not only in skeletal and cardiac muscle development, but also in
CC       neuronal differentiation and survival. Plays diverse roles in the
CC       control of cell growth, survival and apoptosis via p38 MAPK signaling
CC       in muscle-specific and/or growth factor-related transcription. Plays a
CC       critical role in the regulation of neuronal apoptosis (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Forms a complex with class II HDACs in undifferentiating
CC       cells. On myogenic differentiation, HDACs are released into the
CC       cytoplasm allowing MEF2s to interact with other proteins for
CC       activation. Interacts with HDAC4 (in undifferentiating cells); the
CC       interaction translocates MEF2D to nuclear dots (By similarity). Forms a
CC       heterodimer with MEF2A (By similarity). Interacts with MAPK7; the
CC       interaction phosphorylates but does not activate MEF2D
CC       (PubMed:9753748). Interacts with MYOG (By similarity). Interacts with
CC       CCAR2 and HDAC3 (By similarity). {ECO:0000250|UniProtKB:Q14814,
CC       ECO:0000250|UniProtKB:Q63943, ECO:0000269|PubMed:9753748}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Translocated by HDAC4 to nuclear
CC       dots. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on Ser-430 by CDK5 is required for Lys-425
CC       sumoylation and inhibits transcriptional activity. In neurons, enhanced
CC       CDK5 activity induced by neurotoxins promotes caspase 3-mediated
CC       cleavage leading to neuron apoptosis. Phosphorylation on Ser-180 can be
CC       enhanced by EGF. Phosphorylated and activated by CaMK4 (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Acetylated on Lys-425 by CREBBP. Acetylated by EP300. Deacetylated
CC       by SIRT1 and HDAC3 (By similarity). {ECO:0000250|UniProtKB:Q14814}.
CC   -!- PTM: Sumoylated on Lys-425 with SUMO2 but not SUMO1; which inhibits
CC       transcriptional activity and myogenic activity. Desumoylated by SENP3
CC       (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ005425; CAA06531.1; -; mRNA.
DR   EMBL; BC081790; AAH81790.1; -; mRNA.
DR   RefSeq; NP_110487.2; NM_030860.2.
DR   RefSeq; XP_017446620.1; XM_017591131.1.
DR   AlphaFoldDB; O89038; -.
DR   SMR; O89038; -.
DR   BioGRID; 249515; 5.
DR   STRING; 10116.ENSRNOP00000041061; -.
DR   GlyGen; O89038; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O89038; -.
DR   PhosphoSitePlus; O89038; -.
DR   PaxDb; 10116-ENSRNOP00000041061; -.
DR   GeneID; 81518; -.
DR   KEGG; rno:81518; -.
DR   AGR; RGD:621489; -.
DR   CTD; 4209; -.
DR   RGD; 621489; Mef2d.
DR   eggNOG; KOG0014; Eukaryota.
DR   InParanoid; O89038; -.
DR   OrthoDB; 448298at2759; -.
DR   PhylomeDB; O89038; -.
DR   Reactome; R-RNO-525793; Myogenesis.
DR   PRO; PR:O89038; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0007512; P:adult heart development; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.
DR   CDD; cd00265; MADS_MEF2_like; 1.
DR   Gene3D; 3.40.1810.10; Transcription factor, MADS-box; 1.
DR   InterPro; IPR022102; HJURP_C.
DR   InterPro; IPR050142; MADS-box/MEF2_TF.
DR   InterPro; IPR033896; MADS_MEF2-like.
DR   InterPro; IPR002100; TF_MADSbox.
DR   InterPro; IPR036879; TF_MADSbox_sf.
DR   PANTHER; PTHR48019:SF197; MYOCYTE ENHANCER FACTOR 2D; 1.
DR   PANTHER; PTHR48019; SERUM RESPONSE FACTOR HOMOLOG; 1.
DR   Pfam; PF12347; HJURP_C; 1.
DR   Pfam; PF00319; SRF-TF; 1.
DR   PRINTS; PR00404; MADSDOMAIN.
DR   SMART; SM00432; MADS; 1.
DR   SUPFAM; SSF55455; SRF-like; 1.
DR   PROSITE; PS00350; MADS_BOX_1; 1.
DR   PROSITE; PS50066; MADS_BOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Apoptosis; Developmental protein; Differentiation;
KW   DNA-binding; Isopeptide bond; Neurogenesis; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..507
FT                   /note="Myocyte-specific enhancer factor 2D"
FT                   /id="PRO_0000366974"
FT   DOMAIN          3..57
FT                   /note="MADS-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00251"
FT   DNA_BIND        58..86
FT                   /note="Mef2-type"
FT                   /evidence="ECO:0000255"
FT   REGION          174..207
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          244..267
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          357..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          423..507
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        174..196
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..390
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        433..448
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63943"
FT   MOD_RES         121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         180
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         190
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q63943"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         245
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14814"
FT   MOD_RES         251
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         425
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14814"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14814"
FT   CROSSLNK        425
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        208
FT                   /note="R -> G (in Ref. 2; AAH81790)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   507 AA;  54368 MW;  303D4A865805FA41 CRC64;
     MGRKKIQIQR ITDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNH SNKLFQYAST
     DMDKVLLKYT EYNEPHESRT NADIIETLRK KGFNGCDSPE PDGEDSLEQS PLLEDKYRRA
     SEELDGLFRR YGSSVPAPNF AMPVTVPVSN QSSMQFSNPS SSLVTPSLVT SSLTDPRLLS
     PQQPALQRNS VSPGLPQRPA SAGAMLGRDL NSANGACPNP VGNGYVSARA SPGLLPVANG
     NGLNKVIPAK SPPPPTHNTQ LGAPSRKPDL RVITSQGGKG LMHHLNNAQR LGVSQSTHSL
     TTPVVSVATP SLLSQGLPFS SMPTAYNTDY QLPSAELSSL PAFSSPAGLA LGNVTAWQQP
     QQPQQPQPPQ PPQSQPQPPQ PQPQQPPQQQ PHLVPVSLSN LIPGSPLPHV GAALTVTTHP
     HISIKSEPVS PSRERSPAPP PPAVFPAARP EPGEGLSSPA GGSYETGDRD DGRGDFGPTL
     GLLRPAPEPE AEGSAVKRMR LDTWTLK
//
